I have always thought the ADAPT IP had enormous value and that’s why I acquired while many dumped AHZ. . Investors who bailed when the vaccine project failed to realise its early promise would be very disappointed . It would be very interesting to see if this new shingles vaccine resembles the AHZ vaccine as shingles is part of the herpes family
GLTATH
The latent value in the Adapt treatment process., page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.98 |
Change
-0.140(2.29%) |
Mkt cap ! $92.99M | |||
| Open | High | Low | Value | Volume |
| $6.01 | $6.08 | $5.95 | $28.28K | 4.712K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $5.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.07 | 2710 | 2 |
View Market Depth
| Last trade - 13.16pm 26/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |